Announcements Trials
Browse Landscape

Status

Completed 2

Sponsor Class

INDUSTRY 2

Study Type

Interventional 12Observational 2

Sponsor

Cancer Type

Classical hematology 2

Conditions

Anemia 2Neoplasms 1

Interventions

Rivaroxaban 8Surveys and Questionnaires 7Heparin, Low-Molecular-Weight 5apixaban 4fludarabine 3Blood Specimen Collection 3pegfilgrastim 2epoetin beta 2Therapeutics 2Polymerase Chain Reaction 2Piperacillin, Tazobactam Drug Combination 2Observation 2Microarray Analysis 2Melphalan 2Influenza Vaccines 2Immunoenzyme Techniques 2Flow Cytometry 2Epoetin Alfa 2Data Collection 2Dabigatran 2Biopsy 2ziprasidone 1ribociclib 1ravulizumab 1palbociclib 1oprelvekin 1iron isomaltoside 1000 1fludarabine phosphate 1edoxaban 1calcium heparin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Observational × epoetin beta × Classical hematology × Clear all
NCT01809314 2016-08-19

An Observational Study of Epoetin Beta (NeoRecormon) in Participants With Cancer Receiving Chemotherapy

Hoffmann-La Roche

Completed
1,167 enrolled 8 charts
Classical hematology

Anemia

NCT01168349 2015-10-02

An Observational Study of NeoRecormon (Epoetin Beta) in Cancer Patients With Anemia (FAST)

Hoffmann-La Roche

Completed
1,060 enrolled 36 charts
Classical hematology

Anemia, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡